In the same study, Wan et al. demonstrated that the blockade of ATP release by carbenoxolone (CBX), or promoting ATP degradation by a potent ATPase (apyrase), reduced eATP levels in the colon and attenuated DSS-induced colitis [48]. This evidence concerns the gene DNAH8 and colitis.